9
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Leser–Trélat sign: current observations

Pages 541-546 | Published online: 10 Jan 2014

References

  • Shah KR, Boland CR, Patel M, Thrash B, Menter A. Cutaneous manifestations of gastrointestinal disease: part I. J. Am. Acad. Dermatol. 68, e1–e21 (2013).
  • Rampen FHJ, Schwengle LEM. The sign of Leser–Trélat: does it exist? J. Am. Acad. Dermatol. 21, 50–55 (1989).
  • Lindelöf B, Sigurgeirsson B, Melander S. Seborrheic keratosis and cancer. J. Am. Acad. Dermatol. 26, 947–950 (1992).
  • Fink AM, Filz D, Krajnik G, Jurecka W, Ludwig H, Steiner A. Seborrhoeic keratosis in patients with internal malignancies: a case-control study with prospective accrual of patients. J. Eur. Acad. Dermatol. Venereol. 23, 1316–1319 (2009).
  • Westrom DR, Berger TG. The sign of Leser–Trélat in a young man. Arch. Dermatol. 122, 1356–1357 (1986).
  • Barron LA, Prendiville JS. The sign of Leser–Trélat in a young woman with osteogenic sarcoma. J. Am. Acad. Dermatol. 26, 344–347 (1992).
  • Holdiness MR. On the classification of the sign of Leser–Trélat. J. Am. Acad. Dermatol. 19, 754–757 (1988).
  • Yeh JSM, Munn SE, Plunkett TA, Harper PG, Hopster DJ, du Vivier AW. Coexistence of acanthosis nigricans and the sign of Leser–Trélat in a patient with gastric adenocarcinoma: A case report and literature review. J. Am. Acad. Dermatol. 42, 357–362 (2000).
  • da Rosa AC, Pinto GM, Bortoluzzi JS, Duquia RP, de Almeida HLJr. Three simultaneous paraneoplastic manifestations (ichthyosis acquisita, Bazex syndrome, and Leser–Trélat sign) with prostate adenocarcinoma. J. Am. Acad. Dermatol. 61, 538–540 (2009).
  • Moore RL, Devere TS. Epidermal manifestations of internal malignancy. Dermatol. Clin. 26, 17–29 (2008).
  • Yamamoto T, Yokoyama A. Hereditary onset of multiple seborrheic keratosis: a variant of Leser–Trélat sign? J. Dermatol. 23, 191–195 (1996).
  • Heng MC, Soo-Hoo K, Levine S, Petresek D. Linear seborrheic keratosis associated with underlying malignancy. J. Am. Acad. Dermatol. 18, 1316–1321 (1988).
  • Fetil E, Ozkan S, Gürler N, Kusku E, Arda F, Günes AT. Recurrent leser–trelat sign associated with two malignancies. Dermatology 204, 254–255 (2002).
  • Ponti G, Luppi G, Losi L, Giannetti A, Seidenari S. Leser–Trélat syndrome in patients affected by six multiple metachronous primitive cancers. J. Hematol. Oncol. 3, 2 (2010).
  • Abakka S, Elhalouat H, Khoummane N et al. Uterine leiomyosarcoma and Leser–Trélat sign. Lancet 381, 88 (2013).
  • Fanti PA, Metri M, Patrizi A. The sign of Leser–Trélat associated with malignant melanoma. Cutis 44, 39–41 (1989).
  • Cohen JH, Lessin SR, Vowels BR, Benoit B, Witmer WK, Rook AH. The sign of Leser–Trélat in association with Sézary syndrome: simultaneous disappearance of seborrheic keratosis and malignant T-cell clone during combined therapy with photopheresis and interferon alpha. Arch. Dermatol. 129, 1213–1215 (1993).
  • Fasoldt JJ, Brumwell ER, Lackey JN. Leser–Trélat sign presenting in a patient with recurrent pre-B-cell acute lymphocytic leukemia. Cutis 89, 33–35 (2012).
  • Inamadar AC, Palit A. Eruptive seborrhoeic keratosis in human immunodeficiency virus infection: a coincidence or ‘the sign of Leser–Trélat’? Br. J. Dermatol. 149, 435–436 (2003).
  • Hsu C, Abraham S, Campanelli A, Saurat JH, Piguet V. Sign of Leser–Trélat in a heart transplant recipient. Br. J. Dermatol. 153, 861–862 (2005).
  • Da Costa Franca AF, Siqueira NS, Carvalheira JB, Saad MJ, Souza EM. Acanthosis nigricans, tripe palms and the sign of Leser–Trélat in a patient with a benign hepatic neoplasia. J. Eur. Acad. Dermatol. Venereol. 21, 846–848 (2007).
  • Flugman SL, McClain SA, Clark RAF. Transient eruptive seborrheic keratosis associated with erythrodermic psoriasis and erythrodermic drug eruption: report of two cases. J. Am. Acad. Dermatol. 45, S212–S214 (2001).
  • Safa G, Darrieux L. Leser–Trélat sign without internal malignancy. Case Rep. Oncol. 4, 175–177 (2011).
  • Kilmer SL, Berman B, Morhenn VB. Eruptive seborrheic keratosis in a young woman with acromegaly. J. Am. Acad. Dermatol. 23, 991–994 (1990).
  • Girolomoni G, Phillips JT, Bergstresser PR. Prolactin stimulates proliferation of cultured human keratinocytes. J. Invest. Dermatol. 101, 275–279 (1993).
  • González-Castro U, Castells-Rodellas A, Krueger JG. Identification of a novel keratinocyte migration derived from bovine pituitary glands. Arch. Dermatol. Res. 289, 309–316 (1997).
  • Kanda N, Shibata S, Tada Y, Nashiro K, Tamaki K, Watanabe S. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur. J. Immunol. 39, 996–1006 (2009).
  • Hafner C, Vogt T. Seborrheic keratosis. J. Dtsch. Dermatol. Ges. 6, 664–677 (2008).
  • Blomberg M, Jeppesen EM, Skovby F, Benfeldt E. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature. Dermatology 220, 297–305 (2010).
  • Furue M, Kohda F, Duan H et al. Spontaneous regression of multiple seborrheic keratoses associated with nasal carcinoma. Clin. Exp. Dermatol. 26, 705–709 (2001).
  • Nanney LB, Ellis DL, Levine J, King LE. Epidermal growth factor receptors in idiopathic and virally induced skin diseases. Am. J. Pathol. 140, 915–925 (1992).
  • Wilgenbus K, Lentner A, Kuckelkorn R, Handt St, Mittermayer Ch. Further evidence that acanthosis nigricans maligna is linked to enhanced secretion by the tumour of transforming growth factor alpha. Arch. Dermatol. Res. 284, 266–270 (1992).
  • Ellis DL, Kafka SP, Chow JC et al. Melanoma, growth factors, acanthosis nigricans, the sign of Leser–Trélat, and multiple acrochordons: a possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N. Engl. J. Med. 317, 1582–1587 (1987).
  • Koyama S, Ikeda K, Sato M et al. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J. Gastroenterol. 32, 71–77 (1997).
  • Kameya S, Noda A, Isobe E et al. The sign of Leser–Trélat associated with carcinoma of the stomach. Am. J. Gastroenterol. 83, 664–666 (1988).
  • Williams JV, Helm KF, Long D. Chemotherapy-induced inflammation in seborrheic keratosis mimicking disseminated herpes zoster. J. Am. Acad. Dermatol. 40, 643–644 (1999).
  • Miura T, Yamamoto T. Eruptive poromatosis following radiotherapy. Am. J. Dermatopathol. 35, 615–617 (2013).
  • Morton CA, Shuttleworth D, Douglas WS. Porokeratosis and Crohn’s disease. J. Am. Acad. Dermatol. 32, 894–897 (1995).
  • Yamamoto T, Takayama K, Igawa K, Yamanaka M, Ueno M, Yokozeki H. Eruptive sebaceous hyperplasia in association with chronic renal failure. Clin. Exp. Dermatol. 34, e244–e245 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.